Tuesday’s Biggest Winners and Losers in the S&P 500
Tuesday was a relatively positive day for the markets with all of the major U.S. exchanges posting a gain, if only a little. Crude oil started out negative but came on strong in the…
Tuesday was a relatively positive day for the markets with all of the major U.S. exchanges posting a gain, if only a little. Crude oil started out negative but came on strong in the…
Nickel sulphate is a key ingredient in the lithium-ion batteries that power electric vehicles, and analysts are predicting this commodity could prove to be very profitable.
After Under Armour reported its most recent results, shares collapsed to a multiyear low. This was the first quarter in which Under Armour did not post revenue growth—what the company is known for.
After seeing the stock’s incredible rally in 2017, it doesn’t seem like anything can stop Facebook, and it looks like analysts agree.
Geron is one of the few biopharma winners on Tuesday, with the health care sector in general pushing slightly lower on the day.
When Pfizer released its third-quarter earnings report before the markets opened on Tuesday, the results and guidance lived up to what analysts expected but weren't enough to placate investors.
Hydraulic fracturing services provider FTS International has amended its filing with the SEC regarding its initial public offering.
It didn't seem like things could get worse after the year that Under Armour has suffered through so far, but here we are. What makes this report especially scary?
Monday was a relatively negative day for the markets with all of the major U.S. exchanges pulling back. Crude oil started out flat but came on strong in the afternoon. The S&P 500 sectors…
In the starting match against Nike, Under Armour has not just blinked, but the company practically fell asleep. Under Armour may be facing some tough choices ahead.
In a decisive move, the Neos Therapeutics board of directors unanimously struck down an acquisition proposal from PDL BioPharma.
Pfizer is scheduled to release its third-quarter financial results before the markets open on Tuesday.
Advanced Accelerator Applications shares made a run early on Monday after it came public that Novartis plans to buy the company.
Endo International saw its shares make a solid gain to start off the week after the firm announced preliminary financial results for its third quarter.
The busiest earnings week of the season has come and gone, but there are still plenty more big names stepping into the spotlight this week.
24/7 Wall St. has put together a preview of Apple, Tesla, some of the larger tech-related companies that are reporting their quarterly results this week.
24/7 Wall St. has collected a few pharma and biotech catalysts that are coming up on the calendar in November and December.
Alphabet rocked the markets with its most recent earnings report, shattering expectations on the bottom line and sending the stock again to all-time highs.
Out of all the biotechs that reported earnings last week, Gilead Sciences seems to be the one that hasn’t been taking its medicine in 2017.
Friday was an incredible day for the markets, specifically the tech sector. The Nasdaq notched an all-time high and huge gain on the day following the earnings results of Alphabet, Amazon, and Microsoft. Crude…